Trials / Conditions / Stage IIB Pancreatic Cancer

Stage IIB Pancreatic Cancer

20 registered clinical trials studyying Stage IIB Pancreatic Cancer.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer NCT03825289	University of Utah	Phase 1
Completed	VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer NCT03373188	Emory University	Phase 1
Completed	Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190	Stanford University	N/A
Terminated	Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study NCT02345460	Case Comprehensive Cancer Center	Phase 2
Completed	Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P NCT02511821	City of Hope Medical Center	N/A
Completed	Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Canc NCT02349867	Virginia Commonwealth University	Phase 1
Completed	Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer NCT02307539	City of Hope Medical Center	N/A
Completed	Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer NCT01918644	University of Wisconsin, Madison	Phase 1
Completed	Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer NCT02047474	Yale University	Phase 2
Withdrawn	Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery NCT01954732	Case Comprehensive Cancer Center	Phase 1
Withdrawn	Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancr NCT02414100	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	—
Completed	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520	City of Hope Medical Center	N/A
Completed	Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer NCT01959672	University of Nebraska	Phase 2
Terminated	Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or NCT01739439	Fox Chase Cancer Center	Phase 1
Terminated	Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer NCT01897454	Albert Einstein College of Medicine	Phase 2
Completed	Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreati NCT01234935	Translational Oncology Research International	Phase 2
Terminated	RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer NCT01192763	National Cancer Institute (NCI)	Phase 1
Completed	Perioperative Therapy for Resectable Pancreatic Cancer NCT00609336	University of Washington	Phase 2
Terminated	Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery NCT00482625	National Cancer Institute (NCI)	Phase 2
Completed	Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patien NCT00305877	National Cancer Institute (NCI)	Phase 2